ArticleNeoplasia (New York, N.Y.)2012

Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.

Maria Buoncervello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.